KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $93.9 million.

  • Oscar Health's Change in Accured Expenses rose 17066.22% to $93.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $205.5 million, marking a year-over-year increase of 3450.98%. This contributed to the annual value of $205.5 million for FY2025, which is 3450.98% up from last year.
  • Latest data reveals that Oscar Health reported Change in Accured Expenses of $93.9 million as of Q4 2025, which was up 17066.22% from -$30.0 million recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Change in Accured Expenses ranged from a high of $199.6 million in Q1 2025 and a low of -$58.0 million during Q2 2025
  • Over the past 5 years, Oscar Health's median Change in Accured Expenses value was $18.8 million (recorded in 2021), while the average stood at $24.3 million.
  • In the last 5 years, Oscar Health's Change in Accured Expenses tumbled by 118215.08% in 2023 and then soared by 388781.51% in 2024.
  • Quarter analysis of 5 years shows Oscar Health's Change in Accured Expenses stood at $72.8 million in 2021, then crashed by 39.63% to $44.0 million in 2022, then crashed by 72.29% to $12.2 million in 2023, then soared by 184.66% to $34.7 million in 2024, then skyrocketed by 170.66% to $93.9 million in 2025.
  • Its last three reported values are $93.9 million in Q4 2025, -$30.0 million for Q3 2025, and -$58.0 million during Q2 2025.